Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

302
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
302
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

251
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
251
Analgesia and Pain Management01:25

Analgesia and Pain Management

625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

736
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
736
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

860
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
860
Pharmacovigilance01:19

Pharmacovigilance

838
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
838

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance-Based Usability of Medication Adherence Technologies Among Older Adults With Diverse Capabilities: Quantitative Study.

JMIR aging·2026
Same author

Infection prevention and control measures for Ebola and Marburg disease: a series of rapid reviews.

BMJ open·2026
Same author

Identification of Potentially Inappropriate Medications for Adults Below 65 Years: Protocol for a Modified Delphi Study.

JMIR research protocols·2026
Same author

Safety of antibiotic audit and feedback: secondary analysis of a randomized controlled trial.

The Journal of antimicrobial chemotherapy·2026
Same author

Association between initial benzodiazepine prescribing patterns and time to benzodiazepine discontinuation: A population-based retrospective cohort study.

PLoS medicine·2026
Same author

Implications of relying on manufacturer patient support programs for access to high-cost specialty and biologic medicines: a critical qualitative study.

BMJ open·2026

Related Experiment Video

Updated: Jul 6, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Experiences and Outcomes of Using e-Prescribing for Opioids: Rapid Scoping Review.

Sara J T Guilcher1,2,3,4, Stephanie R Cimino1,4, Mina Tadrous1

  • 1Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.

Journal of Medical Internet Research
|December 28, 2023
PubMed
Summary

Electronic prescribing (e-prescribing) shows promise for managing opioid therapy, potentially reducing errors. Further research is needed on prescriber, pharmacist, and patient experiences, especially in primary care settings.

Keywords:
e-prescribingopioid prescriptionopioid userapid scoping review

More Related Videos

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.2K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.7K

Related Experiment Videos

Last Updated: Jul 6, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.2K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.7K

Area of Science:

  • Health Informatics
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Electronic prescribing (e-prescribing) systems aim to enhance prescription safety and appropriateness.
  • The impact of e-prescribing on opioid therapy management, including patient and clinician experiences, remains largely unexplored.

Purpose of the Study:

  • To conduct a rapid scoping review to explore the clinical use of e-prescribing for opioids.
  • To examine the effects of e-prescribing on clinical outcomes, experiences, service delivery, and policy.
  • To identify gaps in current literature to guide future research and recommendations.

Main Methods:

  • A rapid scoping review followed JBI 2020 and WHO rapid review guidelines.
  • A comprehensive literature search was conducted across MEDLINE, Embase, and Scopus databases until November 16, 2022.
  • Included primary research studies on opioid e-prescribing, with an ambulatory care component; data were synthesized descriptively.

Main Results:

  • 34 articles met inclusion criteria, predominantly peer-reviewed studies (94%).
  • Most studies (36%) focused on e-prescribing from acute to community settings; only 3% addressed primary care.
  • Key outcomes included opioid prescribing rates, alert functionalities, prescription quantity/duration, technology adoption, and implementation challenges; e-prescribing may reduce errors.

Conclusions:

  • E-prescribing demonstrates initial promise in opioid therapy management.
  • Future research should focus on prescriber, pharmacist, and patient experiences, particularly in community and primary care.
  • Developing quality indicators and understanding implementation factors are crucial for integrating e-prescribing into clinical practice.